Scientific Digital Imaging plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, including life sciences, healthcare, astronomy, manufacturing and art conservation, announces concurrent with the announcement made today by DeepMatter plc (AIM:DMTR) (“DeepMatter”), that on 15 January 2019 the Group’s subsidiary, Synoptics Limited, acquired the Scanning Ion Conductance Microscope (“SICM”) business of DeepMatter (the “Acquisition”).
The Acquisition, by way of an asset purchase agreement, complements the existing product offering of Synoptics. The SICM business under the Ionscope brand will be managed alongside the existing Synoptics brands of Syngene, Synbiosis and Synoptics Health. The Acquisition is not a substantial transaction for SDI under the AIM Rules for Companies.
The post Synoptics Ltd acquires the Scanning Ion Conductance Microscope (SICM) business of DeepMatter (Ionscope) appeared first on Ionscope.